51 Biggest Movers From Yesterday

Gainers

Sierra Oncology, Inc. (NASDAQ:SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients who are symptomatic, anemic, and previously treated with an FDA-approved JAK inhibitor. The company also entered into a term loan agreement with Oxford Finance LLC to support the commercial preparation and potential launch of momelotinib.
Aptorum Group Limited (NASDAQ:APM) shares gained 38.9% to close at $22.68 after gaining around 10% on Monday. The FDA recently granted Orphan Drug Designation to Aptorum Group’s SACT-1, a repurposed small molecule compound for Neuroblastoma.
Exela Technologies, Inc. (NASDAQ:XELA) jumped 33% to settle at $0.55 after the company announced a renewal of its services contract with a consulting firm. The total contract value is over $35 million.
Vistas Media Acquisition Company Inc. (NASDAQ:VMAC) gained 27.3% to close at $13.90. Vistas Media Acquisition Company shareholders recently approved a business combination with Anghami.
Aditxt, Inc. (NASDAQ:ADTX) gained 25.7% to close at $0.4549. Aditxt recently reported submission of 2 requests for emergency use authorization to the FDA for AditxtScore for covid-19 tests to measure quantity and quality of antibodies against covid and variants including omicron.
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) jumped 25.5% to close at $1.17 after the company announced the FDA cleared its Investigational New Drug application, allowing its Phase 2b dose-optimization trial of MM-120 for the treatment of generalized anxiety disorder to proceed.
SmileDirectClub, Inc. (NASDAQ:SDC) gained 24.6% to close at $2.48 after the company announced strategic actions to increase profitability.
ClearOne, Inc. (NASDAQ:CLRO) jumped 23.5% to settle at $1.07.
Bally's Corporation (NYSE:BALY) rose 22.7% to close at $35.85. Standard General, Bally's largest shareholder, submitted proposal to acquire all of the outstanding shares of Bally's common stock not currently owned by the company at a price of $38 per share.
Capricor Therapeutics, Inc. (NASDAQ:CAPR) gained 21.6% to close at $20.28. Capricor Therapeutics said it has entered into a partnership with Japanese pharma company Nippon Shinyaku for the exclusive commercialization and distribution in the U.S. of Capricor's lead asset, CAP-1002, for the treatment of Duchenne muscular dystrophy.
Urban One, Inc. (NASDAQ:UONE) gained 21% to settle at $5.07.
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) jumped 20.6% to close at $0.2123. China SXT Pharmaceuticals recently priced a $3.5 million underwritten public offering of ordinary shares.
Nine Energy Service, Inc. (NYSE:NINE) gained 20.5% to close at $1.35.
Silence Therapeutics plc (NASDAQ:SLN) jumped 20.3% to settle at $21.89.
Progenity, Inc. (NASDAQ:PROG) gained 20.3% to close at $1.54. Progenity recently announced acceptance of two abstracts on treatment of gastrointestinal disorders at ECCO'22.
Digital Brands Group, Inc. (NASDAQ:DBGI) rose 18.4% to close at $1.5150. Digital Brands Group recently announced a definitive agreement to acquire Sundry.

Check out these penny stocks insiders are buying

ToughBuilt Industries, Inc. (NASDAQ:TBLT) rose 17.6% to close at $0.2863.
Virgin Orbit Holdings, Inc. (NASDAQ:VORB) climbed 17.5% to close at $7.99 after dropping 18% on Monday.
Dermata Therapeutics, Inc. (NASDAQ:DRMA) surged 17.1% to close at $1.99.
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) rose 16% to close at $20.28. Allscripts Healthcare Solutions expects Q4 revenue of $390 million - $395 million, better than the consensus of $$386.75 million. SVB Leerink upgraded Allscripts Healthcare from Market Perform to Outperform and raised the price target from $19 to $22.
Turquoise Hill Resources Ltd. (NYSE:TRQ) shares gained 15.9% to close at $17.50. Rio Tinto Plc and the Mongolian government said reached an agreement to end a dispute over the Oyu Tolgoi copper-gold mining project. As part of the agreement, Turquoise Hill Resources will waive debt worth $2.4 billion owed to it by Mongolia.
Vivos Therapeutics, Inc. (NASDAQ:VVOS) jumped 15.6% to close at $2.81. Vivos Therapeutics recently announced significant increases across several key metrics for its SleepImage Home Sleep Apnea Tests.
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) rose 12.3% to close at $2.46 after reporting topline results from registration-enabling trial of cosibelimab in metastatic cutaneous squamous cell carcinoma. HC Wainwright & Co. maintained Checkpoint Therapeutics with a Buy and raised the price target from $17 to $26.
Amarin Corporation plc (NASDAQ:AMRN) gained 9% to close at $3.26.
Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) rose 7.3% to close at $11.70 after reporting upbeat core earnings for its fourth quarter.
Sonder Holdings Inc. (NASDAQ:SOND) rose 7.1% to close at $7.66. JMP Securities, on Monday, initiated coverage on Sonder Holdings with a Market Outperform rating and announced a price target of $12.
Vertical Aerospace Ltd. (NYSE:EVTL) gained 6.5% to close at $8.01.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big stocks insiders are selling

Losers

Integrated Media Technology Limited (NASDAQ:IMTE) shares dropped 21.8% to close at $8.29 on Tuesday. Integrated Media Technology recently announced the completion of the development of its online digital assets trading platform "Ouction."
Aerojet Rocketdyne Holdings, Inc. (NYSE:AJRD) dipped 18.6% to close at $36.65 on Tuesday. Aerojet Rocketdyne on Lockheed Transaction said, 'We believe it is highly likely that the FTC will vote to sue to block the transaction and expect they will make a decision before Jan. 27, 2022.'
GlucoTrack, Inc. (NASDAQ:IGAP) dropped 17.3% to close at $3.29.
Equitrans Midstream Corporation (NYSE:ETRN) fell 17.3% to settle at $8.59.
Yoshitsu Co., Ltd (NASDAQ:TKLF) fell 16.4% to close at $3.92.
Matinas BioPharma Holdings, Inc. (NYSE:MTNB) declined 16.2% to close at $0.67.
AgileThought, Inc. (NASDAQ:AGIL) dropped 15.9% to close at $4.27. AgileThought recently named Kevin Johnston as COO.
Gelesis Holdings, Inc. (NYSE:GLS) declined 15.6% to settle at $5.59.
Pintec Technology Holdings Limited (NASDAQ:PT) fell 14.9% to close at $0.56 after dipping more than 52% on Monday.
Gracell Biotechnologies Inc. (NASDAQ:GRCL) declined 14.3% to settle at $3.72.
Impac Mortgage Holdings, Inc. (NYSE:IMH) dropped 14.2% to close at $0.8411.
89bio, Inc. (NASDAQ:ETNB) dipped 13.6% to close at $8.29. 89bio announced topline results from a cohort of 20 patients (Cohort 7) in the Phase 1b/2a proof-of-concept study evaluating pegozafermin (formerly BIO89-100) for nonalcoholic steatohepatitis (NASH).
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) dropped 12.4% to close at $3.46. Accelerate Diagnostics Director Jack Schuler recently acquired a total of 41,912 shares at an average price of $3.94.
Instil Bio, Inc. (NASDAQ:TIL) fell 11.5% to close at $11.87.
Kidpik Corp. (NASDAQ:PIK) fell 11.1% to close at $6.31.
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) fell 11.1% to close at $1.04 after gaining around 5% on Monday.
Jianpu Technology Inc. (NYSE:JT) dropped 10.7% to close at $0.9107.
HashiCorp, Inc. (NASDAQ:HCP) fell 10.6% to close at $55.51.
Vertex Energy, Inc. (NASDAQ:VTNR) fell 9.7% to close at $3.81. Clean Harbors and Vertex Energy mutually agreed to terminate planned acquisition of Vertex’s used motor oil collection and re-refining assets.
AMTD International Inc. (NASDAQ:HKIB) fell 7% to close at $4.00 after dropping over 15% on Monday.
IGM Biosciences, Inc. (NASDAQ:IGMS) fell 6.7% to settle at $18.56.
General Electric Company (NYSE:GE) fell 6% to close at $91.11 after the company reported worse-than-expected Q4 sales results.
Shopify Inc. (NYSE:SHOP) fell around 5% to close at $892.39 after Keybanc lowered its price target on the stock from $1750 to $1250.
Xerox Holdings Corporation (NYSE:XRX) fell 4.8% to close at $19.98. Xerox reported a fourth-quarter FY21 sales decline of 7.9% year-on-year, to $1.78 billion, missing the consensus of $1.82 billion.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.